Abstract
A domain at the NH2 terminal (N-terminal) of tumor necrosis factor receptor (TNFR) termed the pre-ligand binding assembly domain (PLAD). The finding that PLAD can mediate a selective TNFR assembly in previously researches provides a novel target to the prevention of TNFR signaling in immune-mediated inflammatory diseases (IMID). In this study, a natural N-terminal TNFR1 PLAD was obtained for the first time through the methods of GST-tag fusion protein expression and enterokinase cleavage. After purification with a Q Sepharose Fast Flow column, a natural N-terminal TNFR1 PLAD which purity was up to 95%, was obtained and was identified using Nano LC-ECI-MS/MS. Secondary structure analysis of PLAD was carried out using circular dichroism spectra (CD). After that, the TNFR1 PLAD in vitro anti-TNFα activity and the specific TNFR1 affinity were determined. The results proved that the natural N-terminal TNFR1 PLAD can selectively inhibit TNFα bioactivity mainly through TNFR1. It infers an effective and safe strategy for treating variety of IMID with a low risk of side effects in future.
Similar content being viewed by others
Abbreviations
- TNFR:
-
Tumor necrosis factor receptor
- PLAD:
-
Pre-ligand binding assembly domain
- IMID:
-
Immune-mediated inflammatory diseases
- GST:
-
Glutathione S-transferase
- IPTG:
-
Lactose analog isopropyl β-D-thiogalactoside
- PVDF:
-
Polyvinylidene difluoride membrane
- MTT:
-
(4,4-Dimethylthiazol-2-yl) 2,5-diphenyl tetrazolium bromide
- OPD:
-
o-Phenylenediamine dihydrochloride
- LB:
-
Luria-Bertani
- ELISA:
-
Enzyme-linked immunosorbent assay
- DAB:
-
Diaminobenzidine
- TFA:
-
Trifluoroacetic acid
- CD:
-
Circular dichroism spectra
References
Adachi T, Toishi T, Takashima E, Hara H (2006) Biol Pharm Bull 10(29):2095–2098
Aderka D, Engelmann H, Maor Y, Brakebusch C, Wallach D (1992) J Exp Med 2(175):323–329
Aggarwal BB, Eessalu TE, Hass PE (1985) Nature 6047(318):665–667
Bradley JR (2008) J Pathol 2(214):149–160
Brown SL, Greene MH, Gershon SK, Edwards ET, Braun MM (2002) Arthritis Rheum 12(46):3151–3158
Chadwick W, Magnus T, Martin B, Keselman A, Mattson MP, Maudsley S (2008) Trends Neurosci 10(31):504–511
Chan FK (2000) Ann Rheum Dis 59(Suppl 1):i50–i53
Chan FK, Chun HJ, Zheng L, Siegel RM, Bui KL, Lenardo MJ (2000) Science 5475(288):2351–2354
Chan KF, Siegel MR, Lenardo JM (2000) Immunity 4(13):419–422
Chen G, Goeddel DV (2002) Science 5573(296):1634–1635
Deng GM (2007) BioDrugs 1(21):23–29
Deng GM, Liu L, Tsokos GC (2009) J Immunol 182 Meeting Abstract Suppl: 50.24
Deng GM, Zheng L, Chan FK, Lenardo M (2005) Nat Med 10(11):1066–1072
Deng GM, Lenardo M (2006) Drug Discov Today Dis Mech 2(3):163–168
Feldmann M (2002) Nat Rev Immunol 5(2):364–371
Feldmann M, Maini RN (2003) Nat Med 10(9):1245–1250
Goldbach-Mansky R, Lipsky PE (2003) Annu Rev Med 54:197–216
Gomez-Reino JJ, Carmona L, Valverde VR, Mola EM, Montero MD (2003) Arthritis Rheum 8(48):2122–2127
Jones DS, Silverman AP, Cochran JR (2008) Trends Biotechnol 9(26):498–505
Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, Siegel JN, Braun MM (2001) N Engl J Med 15(345):1098–1104
MacEwan DJ (2002) Cell Signal 6(14):477–492
Muto Y, Nouri-Aria KT, Meager A, Alexander GJ, Eddleston AL, Williams R (1988) Lancet 8602(2):72–74
Nathan DM, Angus PW, Gibson PR (2006) J Gastroenterol Hepatol 9(21):1366–1371
Shakoor N, Michalska M, Harris CA, Block JA (2002) Lancet 9306(359):579–580
Sheehan KC, Pinckard JK, Arthur CD, Dehner LP, Goeddel DV, Schreiber RD (1995) J Exp Med 2(181):607–617
Shibata H, Yoshioka Y, Ohkawa A, Minowa K, Mukai Y, Abe Y, Taniai M, Nomura T, Kayamuro H, Nabeshi H, Sugita T, Imai S, Nagano K, Yoshikawa T, Fujita T, Nakagawa S, Yamamoto A, Ohta T, Hayakawa T, Mayumi T, Vandenabeele P, Aggarwal BB, Nakamura T, Yamagata Y, Tsunoda S, Kamada H, Tsutsumi Y (2008) J Biol Chem 2(283):998–1007
Shibata H, Yoshioka Y, Ohkawa A, Abe Y, Nomura T, Mukai Y, Nakagawa S, Taniai M, Ohta T, Mayumi T, Kamada H, Tsunoda S, Tsutsumi Y (2008) Cytokine 2(44):229–233
Shibata H, Yoshioka Y, Abe Y, Ohkawa A, Nomura T, Minowa K, Mukai Y, Nakagawa S, Taniai M, Ohta T, Kamada H, Tsunoda S, Tsutsumi Y (2009) Biomaterials 34(30):6638–6647
Acknowledgments
This study was supported by grants from the Jiangsu Provincial Research Innovation Program for College Graduates (CX09B_290Z) and Qing Lan Project.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cao, J., Meng, F., Gao, X. et al. Expression and Purification of a Natural N-Terminal Pre-ligand Assembly Domain of Tumor Necrosis Factor Receptor 1 (TNFR1 PLAD) and Preliminary Activity Determination. Protein J 30, 281–289 (2011). https://doi.org/10.1007/s10930-011-9330-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10930-011-9330-4